SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome

Gajjar A, Raju AK, Gajjar A, Menon M, Shah SAY, Dani S, Weinberg A. SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome. Biomedicines. 2025 Aug 7;13(8):1924. doi: 10.3390/biomedicines13081924. PMID: 40868177.


Related Posts